Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis
- 1 August 1992
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 340 (8818) , 548
- https://doi.org/10.1016/0140-6736(92)91744-s
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Distinct cytoplasmic islet cell antibodies with different risks for Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1992
- Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-alpha (IFN-α)Clinical and Experimental Immunology, 1990
- Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapyCancer, 1990
- Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitisHepatology, 1989
- INDUCTION OF HYPERTHYROIDISM BY INTERFERON-α-2bThe Lancet, 1989
- Thyroid Autoimmunity in Patients on Long Term Therapy with Leukocyte-Derived Interferon*Journal of Clinical Endocrinology & Metabolism, 1986
- In Situ Characterization of Autoimmune Phenomena and Expression of HLA Molecules in the Pancreas in Diabetic InsulitisNew England Journal of Medicine, 1985